CHALLENER, C. A. (2025). Overcoming Biosimilar Scaling Challenges: Process consistency and robustness, analytical excellence, and regulatory compliance are essential in the scale-up of biosimilars. BioPharm International, 38(3), 18-21.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
CHALLENER, CYNTHIA A. "Overcoming Biosimilar Scaling Challenges: Process Consistency and Robustness, Analytical Excellence, and Regulatory Compliance Are Essential in the Scale-up of Biosimilars."
BioPharm International 38, no. 3 (2025): 18-21.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
CHALLENER, CYNTHIA A. "Overcoming Biosimilar Scaling Challenges: Process Consistency and Robustness, Analytical Excellence, and Regulatory Compliance Are Essential in the Scale-up of Biosimilars."
BioPharm International, vol. 38, no. 3, 2025, pp. 18-21.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.